Apr 29, 2023 08:00 AM
Dashenlin Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 34.2% in 2022
00:00/00:00
Listen to this article
1x
Subscribe now
Listen to the full version
Listen to the full version
Dashenlin Pharmaceutical Group Co.,Ltd. (大参林医药集团股份有限公司) (603233.SH) reported a net profit of 1.1 billion yuan in 2022, up 34.2% year-on-year.
Meanwhile, the company posted 21.2 billion yuan in revenue, up 26.8% year-on-year.
At the end of the reporting period, it had 20.8 billion yuan in total assets and 14 billion yuan in total liabilities, with a liability-to-asset ratio of 67.1%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
Share this article
Open WeChat and scan the QR code
- PODCAST
- MOST POPULAR
Sign in with Google
Sign in with Facebook
Sign in with 财新